These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27438603)

  • 1. Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.
    Cao Y; Bansal GP; Merino K; Kumar N
    PLoS One; 2016; 11(7):e0158212. PubMed ID: 27438603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies elicited during natural infection in a predominantly Plasmodium falciparum transmission area cross-react with sexual stage-specific antigen in P. vivax.
    Bansal GP; Vengesai A; Cao Y; Mduluza T; Kumar N
    Acta Trop; 2017 Jun; 170():105-111. PubMed ID: 28257812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization.
    Tachibana M; Suwanabun N; Kaneko O; Iriko H; Otsuki H; Sattabongkot J; Kaneko A; Herrera S; Torii M; Tsuboi T
    Vaccine; 2015 Apr; 33(16):1901-8. PubMed ID: 25765968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
    Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
    mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Conservation of P48/45 Proteins in the Transmission Stages of
    Cao Y; Hart RJ; Bansal GP; Kumar N
    mBio; 2018 Sep; 9(5):. PubMed ID: 30181253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
    Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
    Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes.
    Arévalo-Herrera M; Vallejo AF; Rubiano K; Solarte Y; Marin C; Castellanos A; Céspedes N; Herrera S
    PLoS One; 2015; 10(3):e0119335. PubMed ID: 25775466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.
    Gnidehou S; Mitran CJ; Arango E; Banman S; Mena A; Medawar E; Lima BAS; Doritchamou J; Rajwani J; Jin A; Gavina K; Ntumngia F; Duffy P; Narum D; Ndam NT; Nielsen MA; Salanti A; Kano FS; Carvalho LH; Adams JH; Maestre A; Good MF; Yanow SK
    J Infect Dis; 2019 Jan; 219(1):110-120. PubMed ID: 30534974
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ayadi I; Balam S; Audran R; Bikorimana JP; Nebie I; Diakité M; Felger I; Tanner M; Spertini F; Corradin G; Arevalo M; Herrera S; Agnolon V
    Front Immunol; 2020; 11():574330. PubMed ID: 33193361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.
    de Jong RM; Tebeje SK; Meerstein-Kessel L; Tadesse FG; Jore MM; Stone W; Bousema T
    Immunol Rev; 2020 Jan; 293(1):190-215. PubMed ID: 31840844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax.
    Costa JD; Zanchi FB; Rodrigues FL; Honda ER; Katsuragawa TH; Pereira DB; Taborda RL; Tada MS; Ferreira Rde G; Pereira-da-Silva LH
    Mem Inst Oswaldo Cruz; 2013 Feb; 108(1):98-105. PubMed ID: 23440122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of Plasmodium falciparum asexual stage antigens by antibodies in sera from people exposed to Plasmodium vivax.
    Kumar N; Folgar JP; Lubega P
    Am J Trop Med Hyg; 1992 Oct; 47(4):422-8. PubMed ID: 1279995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of full-length Plasmodium falciparum P48/45 in P. berghei blood stages: A method to express and evaluate vaccine antigens.
    Othman AS; Lin JW; Franke-Fayard BM; Kroeze H; van Pul FJA; Chevalley-Maurel S; Ramesar J; Marin-Mogollon C; Jore MM; Morin MJ; Long CA; Sauerwein R; Birkett A; Miura K; Janse CJ; Khan SM
    Mol Biochem Parasitol; 2018 Sep; 224():44-49. PubMed ID: 30053393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.
    Chowdhury DR; Angov E; Kariuki T; Kumar N
    PLoS One; 2009 Jul; 4(7):e6352. PubMed ID: 19623257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
    Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
    Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against
    Arévalo-Herrera M; Miura K; Cespedes N; Echeverry C; Solano E; Castellanos A; Ramirez JS; Miranda A; Kajava AV; Long C; Corradin G; Herrera S
    Front Immunol; 2021; 12():634738. PubMed ID: 34248932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination.
    Duffy PE
    Expert Rev Vaccines; 2021 Feb; 20(2):185-198. PubMed ID: 33478283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.